1140393

可乐定

United States Pharmacopeia (USP) Reference Standard

• 同義詞: [2-(2,6-二氯苯基)亚氨基]咪唑烷
• 經驗公式（希爾表示法）: C₉H₉Cl₂N₃
• CAS號碼: 4205-90-7
• 分子量：: 230.09
• 分類程式碼代碼: 41116107
• NACRES: NA.24

屬性

• 等級: pharmaceutical primary standard
• API 家族: clonidine
• 製造商／商標名: USP
• 應用: pharmaceutical (small molecule)
• 格式: neat
• InChI: 1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)
• InChI 密鑰: GJSURZIOUXUGAL-UHFFFAOYSA-N

描述

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

應用

• Pharmacological research in hypertension: Clonidine, as an alpha-2 adrenergic agonist, is widely researched for its efficacy in controlling high blood pressure, highlighting its role in cardiovascular studies and its impact on hypertension management (Luo et al., 2023).


• Neuroscience studies on ADHD: Studies utilizing clonidine in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) emphasize its effectiveness as a non-stimulant option, contributing to neuroscience research by exploring its neuromodulatory effects (Goodwin et al., 2023).


• Opioid withdrawal management: Clonidine′s application in mitigating opioid withdrawal symptoms underlines its critical role in addiction medicine, providing a pharmacological approach to support recovery processes (Riccardi et al., 2023).


• Preclinical cardiovascular research: The utilization of clonidine in preclinical studies involves detailed cardiovascular assessments, helping to elucidate the drug′s mechanism in blood pressure regulation and heart rate control, crucial for developing targeted therapies (Salim et al., 2022).


• In vitro pharmacological profiling: Clonidine is extensively used in in vitro studies for pharmacological profiling, helping to determine its interaction with various neurotransmitter systems and its pharmacodynamics (Flinspach et al., 2022).

分析報告

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他說明

Sales restrictions may apply.

安全資訊

• 象形圖: GHS06
• 訊號詞: Danger
• 危險聲明: H301
• 防範說明: P264 - P270 - P301 + P310 - P405 - P501
• 危險分類: Acute Tox. 3 Oral
• 儲存類別代碼: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable